The MediBeacon system uses an optical skin sensor combined with a proprietary agent that glows in the presence of light. The goal is to provide clinicians continuous real-time monitoring of kidney function. MediBeacon has completed clinical studies in healthy and impaired subjects.

The tracer agent and monitor are not yet approved for sale.